Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of clindamycin phosphate foam, 1%. Glenmark’s clindamycin phosphate foam, 1% is bioequivalent and therapeutically equivalent to the ...
Glenmark Pharma ceuticals Inc., USA introduces clindamycin phosphate foam, 1%: Our Bureau, Mumbai Wednesday, February 12, 2025, 12:30 Hrs [IST] Glenmark Pharmaceuticals Inc., USA ...
Glenmark Pharmaceuticals Ltd on Wednesday said its US arm has launched the generic version of Clindamycin Phosphate foam, an.
This new product is bioequivalent and therapeutically equivalent to the reference-listed drug, Evoclin Foam, 1%, manufactured ...
Glenmark Pharmaceuticals has announced the launch of Clindamycin Phosphate Foam, which is a bioequivalent and therapeutically equivalent to the reference listed drug, Evoclin Foam of Mylan ...
Glenmark Pharmaceuticals's US arm has launched a generic version of Clindamycin Phosphate foam, an antibiotic acne treatment.
According to IQVIA sales data for the 12-month period ending December 2024, the Evoclin Foam, 1% market achieved annual sales of approximately $5.8 million ...
The Healthy on MSN3d
Taking an Antibiotic? Here Are the Questions to Ask Your Doctor FirstMake your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or pharmacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback